Health Care: Drugs

Dr. Reddy Laboratories Ltd. (RDY: NYSE)

$42.15 n/a | n/a%
04/17/14 - 04:01 PM ET
Company Profile
Price and Volume
Recent Price 42.15
52 Week High 47.93
52 Week Low 31.32
Avg. Daily Vol. (Mil) 0.29
Beta (3 year) 1.27
Share Related Items
Mkt Cap (Mil) 7,169.70
Shares Out (Mil) 170.10
Float (Mil) 0.00
Dividend Information
Yield % 0.60
Annual Dividend 0.26
Payout Ratio 12.00
Financial Strength
Quick Ratio 1.20
Current Ratio 1.80
LT Debt/ Equity 0.27
Total Debt / Equity 0.58
Valuation Ratios
Price Earnings 19.10
Price/Sales 3.26
Price/Book 5.20
Price/Cash Flow 14.70
Per Share Data
Earnings 2.20
Sales 12.94
Book Value 8.10
Cash Flow 2.86
Business Summary
Dr. Reddy Laboratories, Ltd., is a pharmaceutical company engaged in three businesses: Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Its offers products including Amlodipine, Aprepitant and Finpro-DRLA.
General Information
8-2-337, Road No. 3
Banjara Hills
Hyderabad, An 500 034
www.drreddys.com
Industry : Drugs
Sector: Health Care
Employees: 16617
CEO: Mr. G.V. Prasad
Short Interest
Current Month (Mil) 1.51
Previous Month (Mil) 1.47
Short Interest Ratio (Days) 4.50
Management Effectiveness
Return on Equity 27.30
Return on Assets 13.80
Return on Investments 21.50
Profitability
Gross Margin 60.50
EBIT Margin 22.50
Profit Margin 17.10

Portfolios with RDY

Latest RDY Headlines from TheStreet

More Financial News for RDY

Press Releases for RDY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter